MediciNova, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

MediciNova, Inc. is a late-stage global biopharmaceutical company focused on developing new therapies for neurodegenerative disorders, starting with amyotrophic lateral sclerosis (ALS). It also pursues treatments for a range of other high-need conditions, including respiratory and liver diseases, fibrotic disorders, acute lung injury, and metabolic diseases. The company's work centers on addressing the unmet medical needs of patients and improving their quality of life through its product candidates.

Headquartered in La Jolla, California, the firm operates within the biotechnology research sector and maintains a footprint that is small to mid-sized compared with larger industry players. In early 2026, MediciNova announced partnerships and activities such as a collaboration with Kissei Pharmaceutical Co. to address manufacturing requirements ahead of further clinical development, and it has engaged in investor conferences to share updates on its programs, including ALS trials. These steps illustrate ongoing clinical and external engagement as the company progresses in its late-stage development program.

Sign up for free to view info

Email Format Employee directory